MAPK15 deficiency is also involved in advanced stages through increasing tumor size and lymph node metastasis (Figure 2E–G; Supplementary Figure S1E–G) in ovarian cancer, which suggests that MAPK15 closely participates in tumor development. Here, MAPK15 is linked to neoplasm.